Status:

ENROLLING_BY_INVITATION

Prevalence of Advanced Fibrosis in Patients Living With HIV

Lead Sponsor:

Johannes Gutenberg University Mainz

Conditions:

Fatty Liver Disease

Eligibility:

All Genders

18+ years

Brief Summary

Monocentric, cross-sectional study to define the prevalence of advanced fibrosis in an HIV infected outpatient population. Follow-up over 10 years to assess clinical relevance.

Detailed Description

Globally a shift in the spectrum of diseases has occurred. While in earlier year's infectious (communicable) disease were the main contributors to morbidity and mortality, today non-communicable disea...

Eligibility Criteria

Inclusion

  • informed consent
  • age \>18

Exclusion

  • pregnancy
  • disease with expectation of life under 12 months

Key Trial Info

Start Date :

October 1 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 1 2028

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT04066608

Start Date

October 1 2018

End Date

October 1 2028

Last Update

December 28 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University Medical Center of the Johannes Gutenber Univeristy

Mainz, Germany, 55131

2

University Medical Center of the Johannes Gutenberg University

Mainz, Germany, 55131

Prevalence of Advanced Fibrosis in Patients Living With HIV | DecenTrialz